Bessemer Venture Partners X L.P.

Bessemer Venture Partners X L.P. sold 725,000 shares of HNGE at $40.05 on 2025-11-18; stock now down 25.1% from 52-week high.

Bessemer Venture Partners X L.P., a 10% owner, sold 725,000 shares (725.0K shares) for $29,036,250.00 ($29.0M), reducing holdings from 4,108,707 shares (4.11M shares) to 3,383,707 shares (3.38M shares), a -17.6% reduction in that position batch. The sale occurred at $40.05, and the stock has since declined to $45.36 (within its 52-week range of $34.85–$60.55), currently at -25.1% from the 52-week high and -8.8% over the prior 30 days. At this same ticker (HNGE), Bessemer's prior sell on 2025-05-23 saw the stock rise 75.0% over the subsequent 90 days, indicating that previous sale was not well-timed for a sale before decline. The insider's broader cross-ticker track record shows 5 prior sells with an average 90-day return of +580.2%, but a well-timed rate of 0.00%, meaning those cross-ticker sales consistently occurred before stock gains rather than before declines. The filing contains derivative-conversion activity, meaning the Table I shares_after figure does not represent the full position. Combined with negative recent price momentum (-21.2% over 90 days) and the company's unprofitable fundamentals (net income of $-1.8M on revenue of $154.2M), this sale warrants monitoring.

10% owner Bessemer Venture Partners X L.P. sold 725,066 shares (725.1K) of HNGE at $32.00 for $23.2M on 2025-05-23

Bessemer Venture Partners X L.P., a 10% shareholder, sold 725,066 shares at $32.00 on 2025-05-23, reducing its holdings to 0 shares and generating $23.2M in proceeds. The stock has since risen to $42.13 as of 2025-05-27, just 3 trading days post-transaction and 4 trading days after the 5/23 sale date. This represents a $10.13 per-share divergence between the sale price and current market price, a material gap for a recent-IPO company still establishing price discovery. The filing contains a derivative conversion notation, indicating the seller's economic position may extend beyond Table I common shares into derivative securities holdings not yet populated in our database, so the reported zero post-transaction shares do not represent the insider's total economic stake.

Bessemer Venture Partners X L.P. sold 666,993 shares at blended avg $1.62 across 2 transactions, retaining 18.92M shares (3.4% reduction).

A 10% owner executed 2 separate sales totaling 666,993 shares for $1,081,117.83 on 2024-11-14 and 2024-11-15 at prices of $1.63 and $1.56 respectively. The seller's blended average of $1.62 contrasts with the current price of $1.30, representing a 19.75% decline from transaction execution. Post-transaction holdings of 18.92M shares represent a 3.4% reduction relative to pre-transaction holdings of 19.58M shares, but the seller maintains a substantial majority position. The company's fundamentals remain challenged: latest quarterly revenue stood at $2.4M with a net loss of $14.8M, and annual revenue declined 8.4% year-over-year. This sale occurred within a sequence of three sales in four trading days (2024-11-08, 2024-11-11, 2024-11-14/15), suggesting a broader portfolio reduction from this holder rather than an isolated transaction.

Bessemer Venture Partners X L.P. sold 2,000,000 shares of RGTI for $3,040,000.00 in 2 transactions

Bessemer Venture Partners X L.P., a 10% owner, conducted 2 separate sales totaling 2,000,000 shares (2.00M shares) for $3,040,000.00 at a blended average price of $1.52, reducing holdings by 9.3% to 19,582,218 shares. The sales occurred against a backdrop of significant volatility: the stock is -32.6% from its 52-week high of $2.21 but has posted strong recent momentum with +82.5% gains over 30 days and +77.2% over 90 days. Rigetti Computing faces material operational challenges, reporting only $2,378,000.00 in quarterly revenue and net losses of -$14,833,000.00 in the most recent quarter, with annual revenue declining -8.4% and the company unprofitable over its last full fiscal year. A 10% owner's reduction in stake by 9.3% during a period of positive price momentum, combined with the company's persistent unprofitability and revenue contraction, merits investor review of the reduction's rationale and broader portfolio context.